Form 8-K - Current report:
SEC Accession No. 0001437749-25-030649
Filing Date
2025-10-07
Accepted
2025-10-07 16:15:22
Documents
13
Period of Report
2025-10-07
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20251007_8k.htm   iXBRL 8-K 26340
  Complete submission text file 0001437749-25-030649.txt   156796

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20251007.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20251007_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20251007_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20251007_pre.xml EX-101.PRE 11584
15 EXTRACTED XBRL INSTANCE DOCUMENT bcda20251007_8k_htm.xml XML 2824
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 251380015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)